NCT06517511 2026-02-12Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)Sun Yat-sen UniversityPhase 2 Recruiting42 enrolled
NCT06647940 2024-10-22Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients(Rocket Trial)Sun Yat-sen UniversityPhase 2 Recruiting39 enrolled